Quinolinone-carboxamide compounds as 5-HT4, receptor agonists
1 Assignment
0 Petitions
Accused Products
Abstract
The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
-
Citations
42 Claims
-
1-23. -23. (canceled)
- 24. A method of treating chronic constipation in a mammal, the method comprising administering to the mammal a compound of formula (I):
- 28. A method of treating constipation-predominant irritable bowel syndrome in a mammal, the method comprising administering to the mammal a compound of formula (I):
- 32. A method of treating functional dyspepsia in a mammal, the method comprising administering to the mammal a compound of formula (I):
- 36. A method of treating gastroparesis in a mammal, the method comprising administering to the mammal a compound of formula (I):
- 40. A method of treating a mammal having a disease or medical condition mediated by treatment with a 5-HT4 receptor agonist, wherein the disease or medical condition is chronic constipation, constipation-predominant irritable bowel syndrome, functional dyspepsia, gastroparesis, gastroesophageal reflux disease, or drug-induced delayed transit, the method comprising administering to the mammal, a pharmaceutical composition comprising a pharmaceutically-acceptable carrier and a compound of formula (I):
Specification